Search
Biospace news
RSS Feed for Biotech, Pharmaceutical and Clinical Research News | BioSpace (Generated by New Sloth)
Updated: 8 hours 48 min ago
Rapport Therapeutics Snags $100M for Precision Approach to Neurological Diseases
Rapport Therapeutics Snags $100M for Precision Approach to Neurological Diseases 3/7/2023
Moderna Eyes Accelerated Approval for mRNA Cancer Vaccine
Moderna Eyes Accelerated Approval for mRNA Cancer Vaccine 3/7/2023
Lilly-Backed Volastra Enters Clinic with Amgen’s KIF18A Inhibitor
Lilly-Backed Volastra Enters Clinic with Amgen’s KIF18A Inhibitor 3/7/2023
Merck Preps Potential First Oral PCSK9 Inhibitor for Phase III
Merck Preps Potential First Oral PCSK9 Inhibitor for Phase III 3/7/2023
Small Study of BridgeBio's Dwarfism Drug Indicates Advantage over BioMarin
Small Study of BridgeBio's Dwarfism Drug Indicates Advantage over BioMarin 3/7/2023
AI Therapeutics Posts First Clinical Data for New ALS Mechanism
AI Therapeutics Posts First Clinical Data for New ALS Mechanism 4/6/2023
Hedge Fund Wages Proxy Battle with Exelixis Over R&D
Hedge Fund Wages Proxy Battle with Exelixis Over R&D 4/6/2023
NLRB Rules Severance Agreements with Nondisclosure Clauses are Unlawful
NLRB Rules Severance Agreements with Nondisclosure Clauses are Unlawful 4/6/2023
Pfizer Publishes Phase III RSV Data Ahead of May Decision
Pfizer Publishes Phase III RSV Data Ahead of May Decision 4/6/2023
How the IRA Will Affect Drug Development
How the IRA Will Affect Drug Development 4/6/2023
FDA Sets July Decision Date for Full Approval of Leqembi
FDA Sets July Decision Date for Full Approval of Leqembi 3/6/2023
Voyager Rolls on as Novartis Selects Two of Three CNS Targets
Voyager Rolls on as Novartis Selects Two of Three CNS Targets 3/6/2023
Full Results from Esperion's Cholesterol Drug Fail to Impress Investors
Full Results from Esperion's Cholesterol Drug Fail to Impress Investors 3/6/2023
Incyte Abandons Phase III Trial for Myelofibrosis Treatment
Incyte Abandons Phase III Trial for Myelofibrosis Treatment 3/6/2023
How to Nail Virtual Interviews & Networking Events
How to Nail Virtual Interviews & Networking Events 3/6/2023
FDA Action Alert: Roche and Acadia
FDA Action Alert: Roche and Acadia 3/6/2023
AbbVie’s Rinvoq Maintains Durability in Phase II Lupus Study
AbbVie’s Rinvoq Maintains Durability in Phase II Lupus Study 5/31/2023
FDA Puts Clinical Hold on PepGen’s DM1 Early-Stage Trial
FDA Puts Clinical Hold on PepGen’s DM1 Early-Stage Trial 5/31/2023
Sanofi Rebounds in MS with Mid-Stage Data for Anti-CD40L Antibody
Sanofi Rebounds in MS with Mid-Stage Data for Anti-CD40L Antibody 5/31/2023
Glyscend’s First-in-Class Oral Diabetes Drug Shows Phase II Promise
Glyscend’s First-in-Class Oral Diabetes Drug Shows Phase II Promise 5/31/2023
World Pharma News
- Bayer launches unit to develop new precision health consumer products
- Researchers use ‘natural’ system to identify proteins most useful for developing an effective HIV vaccine
- New blood biomarker can predict if cognitively healthy elderly will develop Alzheimer's disease
- Large study provides scientists with deeper insight into long COVID symptoms
- Pfizer's PAXLOVID™ receives FDA approval for adult patients at high risk of progression to severe COVID-19